Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm Morrissey

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Biorxiv : the Preprint Server for Biology|October 31, 2023
ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate CancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Science Translational Medicine|August 2, 2023
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancersAlvaro Quintanal-Villalonga, Vidushi Durani, Amin Sabet, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Deep learning-based non-invasive profiling of tumor transcriptomes from cell-free DNA for precision oncologyRobert D Patton, Alexander Netzley, Thomas W Persse, et al.
JCI Insight|July 13, 2023
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase functionAnbarasu Kumaraswamy, Zhi Duan, Diana Flores, et al.
The Journal of Clinical Investigation|July 31, 2019
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancerMark P Labrecque, Ilsa M Coleman, Lisha G Brown, et al.
Science Translational Medicine|August 2, 2019
The androgen receptor regulates a druggable translational regulon in advanced prostate cancerYuzhen Liu, Jessie L Horn, Kalyan Banda, et al.
Nucleic Acids Research|June 27, 2024
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Neoplasia (New York, N.Y.)|May 30, 2026
Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancerLisha G Brown, Ilsa M Coleman, Tony L H Chu, et al.
JCI Insight|February 23, 2023
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancerErolcan Sayar, Radhika A Patel, Ilsa M Coleman, et al.
Research Square|January 10, 2024
ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATESAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Biorxiv : the Preprint Server for Biology|October 31, 2023
ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate CancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Science Translational Medicine|August 2, 2023
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancersAlvaro Quintanal-Villalonga, Vidushi Durani, Amin Sabet, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Deep learning-based non-invasive profiling of tumor transcriptomes from cell-free DNA for precision oncologyRobert D Patton, Alexander Netzley, Thomas W Persse, et al.
JCI Insight|July 13, 2023
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase functionAnbarasu Kumaraswamy, Zhi Duan, Diana Flores, et al.
The Journal of Clinical Investigation|July 31, 2019
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancerMark P Labrecque, Ilsa M Coleman, Lisha G Brown, et al.
Science Translational Medicine|August 2, 2019
The androgen receptor regulates a druggable translational regulon in advanced prostate cancerYuzhen Liu, Jessie L Horn, Kalyan Banda, et al.
Nucleic Acids Research|June 27, 2024
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancerChen Qian, Qian Yang, Mirja Rotinen, et al.
Neoplasia (New York, N.Y.)|May 30, 2026
Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancerLisha G Brown, Ilsa M Coleman, Tony L H Chu, et al.
JCI Insight|February 23, 2023
Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancerErolcan Sayar, Radhika A Patel, Ilsa M Coleman, et al.
Research Square|January 10, 2024
ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATESAzra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Pageof 18